0001585364-15-000019.txt : 20150409
0001585364-15-000019.hdr.sgml : 20150409
20150409120029
ACCESSION NUMBER: 0001585364-15-000019
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150330
FILED AS OF DATE: 20150409
DATE AS OF CHANGE: 20150409
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERRIGO Co plc
CENTRAL INDEX KEY: 0001585364
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0627
BUSINESS ADDRESS:
STREET 1: TREASURY BUILDING
STREET 2: LOWER GRAND CANAL STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 269-673-8451
MAIL ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
FORMER COMPANY:
FORMER CONFORMED NAME: PERRIGO Co Ltd
DATE OF NAME CHANGE: 20130828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coucke Marc
CENTRAL INDEX KEY: 0001637692
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36353
FILM NUMBER: 15760779
MAIL ADDRESS:
STREET 1: C/O PERRIGO COMPANY PLC
STREET 2: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
3
1
wf-form3_142859521940208.xml
FORM 3
X0206
3
2015-03-30
0
0001585364
PERRIGO Co plc
PRGO
0001637692
Coucke Marc
C/O PERRIGO COMPANY PLC
515 EASTERN AVENUE
ALLEGAN
MI
49010
0
1
0
0
Executive VP & GM
Ordinary Shares
5397711
I
Alychlo NV
The reporting person and his spouse are the principal shareholders of Alychlo NV ("Alychlo"). On March 30, 2015, Alychlo acquired 5,397,711 ordinary shares of Perrigo Company plc ("Perrigo", and the shares "Perrigo Shares") in connection with Perrigo's acquisition of Omega Pharma Invest NV, all pursuant to a share purchase agreement dated November 6, 2014 (the "Share Purchase Agreement"). Of the 5,397,711 Perrigo Shares issued to Alychlo, 1,081,742 Perrigo Shares are being held in escrow until June 30, 2016 pursuant to the terms of a share escrow agreement, and are subject to possible forfeiture until that time to satisfy indemnity claims arising under the Share Purchase Agreement as specified in the share escrow agreement. After the closing of Alychlo's acquisition of 5,397,711 Perrigo Shares on March 30, 2015, Mylecke Management, Art & Invest NV, represented by Marc Coucke, was appointed Executive Vice President and General Manager of Perrigo's Omega Pharma business unit.
Pursuant to the terms of a lock-up agreement dated March 30, 2015 entered into in connection with the Share Purchase Agreement, without the issuer's prior written consent, the transfer or other disposition of the 5,397,711 Perrigo Shares acquired by Alychlo are restricted 50% until March 30, 2017 and the remaining 50% until March 30, 2018, subject to certain permitted exceptions.
Alychlo NV is a Belgium-based limited liability company in which Marc Coucke and his spouse are the principal shareholders.
/s/ David McConnell, Attorney-in-fact for Mr. Coucke
2015-04-09